Schistosoma mansoni Sirtuins: Characterization and Potential as Chemotherapeutic Targets

PLoS Neglected Tropical Diseases

Volumn 7, Issue 9, 2013, Pages

  Lancelot, Julien ^a   Caby, Stéphanie ^a   Dubois Abdesselem, Florence ^a   Vanderstraete, Mathieu ^a   Trolet, Jacques ^a   Oliveira, Guilherme ^b   Bracher, Franz ^c   Jung, Manfred ^d   Pierce, Raymond J ^a  

^a UNIV LILLE   (France)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIMETHYLPYRAZOLE; ANTHELMINTIC AGENT; HR 103; MITOCHONDRIAL PROTEIN; MS13; SALERMIDE; SIRTINOL; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; SIRTUIN INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; COMPUTER MODEL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG TARGETING; EGG LAYING; EPIGENETIC REPRESSION; FEMALE; MALE; MOLECULAR CLONING; MOLECULAR PHYLOGENY; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PARASITE VIABILITY; PHYLOGENY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCHISTOSOMA MANSONI; SCHISTOSOMULUM; SYRIAN HAMSTER; TREMATODE LIFE CYCLE STAGE;

ANIMALS; ANTHELMINTICS; ENZYME INHIBITORS; FEMALE; HELMINTH PROTEINS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PARASITIC SENSITIVITY TESTS; PHYLOGENY; SCHISTOSOMA MANSONI; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SIRTUINS;

EID: 84884697264     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002428     Document Type: Article

References (64)

1. Fenwick A, Webster JP, Bosque-Oliva E, Blair L, Fleming FM, et al. (2009) The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 136: 1719-1730.
2. Van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
3. Doenhoff MJ, Cioli D, Utzinger J, (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21: 659-67.
4. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, et al. (2009) Reduced susceptibility to praziquantel among naturally occurring Kenya isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3: e504.
5. Fallon PG, Doenhoff MJ, (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-8.
6. Marks PA, Jiang X, (2005) Histone deacetylase inhibitors in programmed cell death and cancer therapy. Cell Cycle 4: 549-551.
7. Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M, (2012) Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 11: 384-400.
8. Pierce RJ, Dubois-Abdesselem F, Lancelot J, Andrade L, Oliveira G, (2012) Targeting schistosome histone modifying enzymes for drug development. Curr Pharm Des 18: 3567-3578.
9. Thompson DP, Morrison DD, Pax RA, Bennett JL, (1984) Changes in glucose metabolism and cyanide sensitivity in Schistosoma mansoni during development. Mol Biochem Parasitol 13: 39-51.
10. Skelly PJ, Shoemaker CB, (1995) A molecular genetic study of the variations in metabolic function during schistosome development. Mem Inst Oswaldo Cruz 90: 281-284.
11. Koppenol WH, Bounds PL, Dang CV, (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11: 325-337.
12. Martinez-Outschoorn UE, Pestell RG, Howell A, Tykocinski ML, Nagajyothi F, et al. (2011) Energy transfer in "parasitic" cancer metabolism. Cell Cycle 10: 4208-4216.
13. Kaelin WG Jr, McKnight SL, (2013) Influence of metabolism on epigenetics and disease. Cell 153: 56-69.
14. Berriman M, Haas B, Loverde PT, Wilson RA, Dillon GP, et al. (2009) The Genome of the blood fluke Schistosoma mansoni. Nature 462: 352-358.
15. Frye RA, (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273: 793-798.
16. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, et al. (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126: 941-54.
17. Du J, Zhou Y, Su X, Yu JJ, Khan S, et al. (2011) Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334: 806-809.
18. Jiang H, Khan S, Wang Y, Charron G, He B, et al. (2013) Sirt6 regulates TNF- secretion through hydrolysis of long-chain fatty acyl lysine. Nature 496: 110-113.
19. Greiss S, Gartner A, (2009) Sirtuin/Sir2 phylogeny, evolutionary considerations and structural conservation. Mol Cells 28: 407-415.
20. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I, (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623-4635.
21. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, et al. (2001) hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
22. Matsuzaki H, Daitoku H, Hatta M, Aoyama H, Yoshimochi K, et al. (2005) Acetylation of FoxO1 alters its DNA-binding ability and sensitivity to phosphorylation. Proc Natl Acad Sci U S A 102: 11278-11283.
23. Houtkooper RH, Pirinen E, Auwerx J, (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13: 225-238.
24. Uciechowska U, Schemies J, Scharfe M, Lawson M, Wichapong K, et al. (2012) Binding free energy calculations and biological testing of novel thiobarbiturates as inhibitors of the human NAD+ dependent histone deacetylase Sirt2. Med Chem Commun 3: 167-173.
25. Wang J, Kim TH, Ahn MY, Lee J, Jung JH, et al. (2012) Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells. Int J Oncol 41: 1101-1109.
26. Lara E, Mai A, Calvanese V, Altucci L, Lopez-Nieva P, et al. (2009) Salermide, a sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 28: 781-791.
27. Tonkin CJ, Carret CJ, Duraisingh MT, Voss TS, Ralph SA, et al. (2009) Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum. PLoS Biol 7: e84.
28. Prusty D, Mehra P, Srivastava S, Shivange AV, Gupta A, et al. (2008) Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth. FEMS Microbiol Lett 282: 266-272.
29. Chakrabarty SP, Saikumari YK, Bopanna MP, Balaram H, (2008) Biochemical characterization of Plasmodium falciparum Sir2, a NAD+-dependent deacetylase. Mol Biochem Parasitol 158: 139-151.
30. Vergnes B, Sereno D, Tavares J, Cordeiro-da-Silva A, Vanhille L, et al. (2005) Targeted disruption of cytosolic SIR2 deacetylase discloses its essential role in Leishmania survival and proliferation. Gene 363: 85-96.
31. Smithers SR, Terry RJ, (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55: 695-700.
32. Yoshino TP, Laursen JR, (1995) Production of Schistosoma mansoni daughter sporocysts from mother sporocysts maintained in synxenic culture with Biomphalaria glabrata embryonic (Bge) cells. J Parasitol 81: 714-722.
33. Bertin B, Oger F, Cornette J, Caby S, Noël C, et al. (2006) Schistosoma mansoni CBP/p300 has a conserved domain structure and interacts functionally with the nuclear receptor SmFtz-F1. Mol Biochem Parasitol 146: 180-191.
34. Ramalho-Pinto FJ, Gazzinelli G, Howells RE, Mota-Santos TA, Figueiredo EA, et al. (1974) Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro. Exp Parasitol 36: 360-372.
35. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, et al. (2012) The Pfam protein families database. Nucl Acids Res 40: D290-301.
36. Hunter S, Apweiler R, Attwoood TK, Bairoch A, Bateman A, et al. (2009) InterPro: the integrative protein signature database. Nucl Acids Res 37: D211-D215.
37. Hall BG, (2013) Building phylogenetic trees from molecular data with MEGA. Mol Biol Evol 30: 1229-35.
38. Cole C, Barber JD, Barton GJ, (2008) The Jpred 3 secondary structure prediction server. Nucl Acids Res 36: W197-201.
39. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29: e45.
40. Dubois F, Caby S, Oger F, Cosseau C, Capron M, et al. (2009) Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. Mol Biochem Parasitol 168: 7-15.
41. Grozinger CM, Chao ED, Blackwell HE, Moazed D, Schreiber SL, (2001) Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem 276: 38837-38843.
42. Uciechowska U, Schemies J, Neugebauer RC, Huda EM, Schmitt ML, et al. (2008) Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testing. ChemMedChem 3: 1965-76.
43. Schmitt ML. (2009) Synthese von Arylidenthiobarbitursäuren als Leitstrukturen neuartiger Sirtuin-Inhibitoren. Diploma thesis, University of Freiburg.
44. Neugebauer RC, Uchiechowska U, Meier R, Hruby H, Valkov V, et al. (2008) Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode. J Med Chem 51: 1203-13.
45. Vanderstraete M, Gouignard N, Caillau K, Morel M, Lancelot J, et al. (2013) Dual targeting of insulin and venus kinase receptors of Schistosoma mansoni for novel anti-schistosome therapy. PLoS Negl Trop Dis 7: e2226.
46. Krautz-Peterson G, Radwanska M, Ndegwa D, Shoemaker CB, Skelly PJ, (2007) Optimizing gene suppression in schistosomes using RNA interference. Mol Biochem Parasitol 153: 194-202.
47. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
48. Reichsteiner M, Rogers SW, (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21: 267-271.
49. Lawlor MA, Alessi DR, (2001) PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910.
50. Protasio AV, Tsai IJ, Babbage A, Nichol S, Hunt M, et al. (2012) A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis 6: e1455.
51. Davis RE, Hardwick C, Tavernier P, Hodgson S, Singh H, (1995) RNA trans-splicing in flatworms. Analysis of trans-spliced mRNAs and genes in the human parasite, Schistosoma mansoni. J Biol Chem 270: 21813-21819.
52. Cheng G, Cohen L, Ndegwa D, Davis RE, (2006) The flatworm spliced leader 3′-terminal AUG as a translation initiator methionine. J Biol Chem 281: 733-743.
53. Nakai K, Horton P, (1999) PSORT: a program for detecting the sorting signals of proteins and predicting their subcellular localization,. Trends Biochem Sci 24: 34-35.
54. Schistosoma japonicum genome sequencing and functional analysis consortium (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460: 345-351.
55. Young ND, Jex AR, Li B, Liu S, Yang L, et al. (2012) Whole-genome sequence of Schistosoma haematobium. Nat Genet 44: 221-225.
56. Tsai IJ, Zarowiecki M, Holroyd N, Garciarrubio A, Sanchez-Flores A, et al. (2013) The genomes of four tapeworm species reveal adaptations to parasitism. Nature 496: 57-63.
57. Jeong SM, Xiao C, Finley LW, Lahusen T, Souza AL, et al. (2013) SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23: 450-463.
58. Rouse J, Jackson SP, (2002) Interfaces between the detection, signaling, and repair of DNA damage. Science 297: 547-551.
59. Zhong L, Mostoslavsky R, (2010) SIRT6: a master gatekeeper of glucose metabolism. Transcription 1: 17-21.
60. Barber MF, Michisita-Kioi E, Xi Y, Tasselli L, Kioi M, et al. (2012) Sirt7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487: 114-118.
61. Peck B, Chen CY, Ho KK, Di Fruscia P, Myatt SS, et al. (2010) SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther 9: 844-855.
62. Heltweg B, Jung M, (2002) A microplate reader-based nonisotopic histone deacetylase activity assay. Anal Biochem 302: 175-183.
63. Coussens M, Maresh JG, Yanagiamachi R, Maeda G, Allsopp R, (2008) Sirt1 deficiency attenuates spermatogenesis and germ cell function. PLoS ONE 3: e1571.
64. Seifert EL, Caron AZ, Morin K, Coulombe J, He XH, et al. (2012) SirT1 catalytic activity is required for male fertility and metabolic homeostasis in mice. FASEB J 26: 555-566.